Auteur/autrice : oxeltis

For 15 years, Oxeltis has been your trusted partner for custom nucleos(t)ide synthesis and drug discovery programs. With more than 1,500 complex nucleos(t)ides synthesized - comprising prodrugs, phosphoramidites and triphosphates- (...)

The 59th International conference on medicinal Chemistry (Orléans-FR June 2nd - 4th) is focused on “drug discovery and selection”, Jean-Marc Allaire (CEO and co-founder) and Christoph Parsy (Business & Strategic (...)

SCT one-day congress on the transformative advances in organic synthetic chemistry (June 3rd, Lille -France) 4th Anglo-Nordic medicinal Chemistry Symposium (June 10-13th, in Suekkersten, Denmark) Bio international convention (June 16-19th, (...)

We are pleased to announce that Stephane Salamone and Christophe Parsy will be welcoming you at Oxeltis booth during ACSMEDI-EFMC Medchem Frontiers meeting in Chicago, USA. We look forward to (...)

For several years Oxeltis has been engaged in a continuous improvement process, implementing new technologies, new scientific training and new H&S procedures with the focus on improving and delivering excellence (...)

Business Developer Biotech/CRO – International F/M Job description Do you want to combine your scientific skills with your business skills?Do you want to join a French company with international clients? (...)

Business developer Biotech/CRO – International F/H Descriptif de poste Vous souhaitez associer vos compétences dans le domaine scientifique à vos compétences commerciales ?Vous souhaitez intégrer une entreprise active à l’international ? Nous (...)

https://www.irt2024.jp/ XXV International Round Table on Nucleosides,Nucleotides and Nucleic Acids at Katsushika Campus,Tokyo University of Science

https://www.efmc-ismc.org The XXVIII EFMC International Symposium on Medicinal Chemistry is organised by the Medicinal Chemistry Division of the Società Chimica Italiana (Italian Chemical Society), on behalf of the European Federation for Medicinal chemistry and Chemical (...)